Geron Corp GERN:NASDAQ

Last Price$1.50NASDAQ Previous Close - Last Trade as of 4:00PM ET 6/28/22

Today's Change+0.09(6.38%)
Bid (Size)$1.45 (1)
Ask (Size)$1.51 (1)
Day Low / High$1.38 - 1.51
Volume657.00
  • Latest Stories
  • Commentary and Analysis
Geron Names Faye Feller Chief Medical Officer
4:28PM ET 6/15/2022 MT Newswires

Geron (GERN) said late Wednesday it named Faye Feller chief medical officer, effective July 9. Feller succeeds Aleksandra Rizo, who will transition to the...

--Needham Trims Geron's Price Target to $2 From $3, Buy Rating Kept
11:14AM ET 5/10/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Geron Completes Stock, Warrant Sale
4:51PM ET 4/01/2022 MT Newswires

Geron (GERN) late Friday said it has closed a public offering of common shares and warrants. The offering covered 53.3 million shares and pre-funded...

Top Premarket Decliners
8:11AM ET 3/30/2022 MT Newswires

Calithera (CALA) shares slumped 33%, adding to Tuesday's losses. Stronghold (SDIG) shares tumbled 30% after the company posted Q4 earnings and revenue that...

Geron Prices Offering of Common Shares, Warrants; Expects $75 Million Gross Proceeds
3:25AM ET 3/30/2022 MT Newswires

Geron (GERN) said Wednesday that it priced its public offering of common shares and pre-funded warrants, for expected gross proceeds of about $75.0...

Geron Plans Securities Offering -- Shares Plunge After-Hours
4:15PM ET 3/29/2022 MT Newswires

Geron (GERN) said late Tuesday it plans to sell an undisclosed number of its common shares and warrants in an underwritten public offering. At the...

Earnings Reaction History: GERON CORP, 44.4% Follow-Through Indicator, 4.2% Sensitive
12:09PM ET 3/10/2022 MT Newswires

Expected Earnings Release: 03/10/2022, After-hours Avg. Extended-Hours Dollar Volume: $343,196 GERON CORP (GERN) is due to issue its quarterly earnings...

--Baird Starts Geron at Outperform With $4 Price Target
5:55AM ET 11/02/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Geron Gets UK's Innovative Passport Label for Imetelstat to Expedite Regulatory Process -- Stock Up 7% After-Hours
5:44PM ET 10/25/2021 MT Newswires

Geron (GERN) said Monday it secured the UK's Innovation Passport, the first prescribed entry point to the Innovative Licensing and Access Pathway by the...

Geron Completes Patient Enrollment in Phase 3 Trial of Imetelstat
8:20AM ET 10/18/2021 MT Newswires

Geron Corp. (GERN) said Monday it has completed enrolling patients for a phase 3 clinical trial of imetelstat in lower risk myelodysplastic syndromes. ...